Oncology News | pharmaphorum

News

Jounce setback casts deeper pall over ICOS as cancer target

A phase 2 trial of Jounce Therapeutics' ICOS agonist vopratelimab has ended in failure, casting further doubt about the validity of ICOS as a target for cancer therapies.

News

Phase 3 trial confirms Lumakras role in lung cancer

Amgen's pathfinder KRAS inhibitor Lumakras has been shown to be effective in KRAS-mutated non-small cell lung cancer (NSCLC) in a phase 3 trial that should serve as a confirmation study for

News

Merck takeover talks with Seagen have hit a hurdle; report

Merck & Co's negotiations with Seagen over a possible takeover have stalled because the two sides cannot agree on a price, according to Bloomberg, citing people familiar with the matter

News

Radiopharma specialist Aktis' first-round financing swells t...

Aktis Oncology has gone back for another bite of the cherry in its Series A round, adding another $84 million to the $72 million raised last year to help bring its radiopharmaceuticals to m

News

Janssen J&J Johnson and Johnson pharmaceutical companies

J&J gets first approval for multiple myeloma bispecific Tecv...

Johnson & Johnson has its first worldwide regulatory approval – in the EU – for Tecvayli, one of two much-anticipated bispecific antibodies the drugmaker has developed for patients with

News

Doctor using mobile smart phone, work on laptop computer with notebook and medical stethoscope on the desk at office. Telehealth, telemedicine or medic tech concept.

NCI sets aside $23m to research telehealth in cancer care

The National Cancer Institute (NCI) in the US has said it will make $23 million available to four academic institutions over the next five years to study the role of telehealth for cancer p

Jounce setback casts deeper pall over ICOS as cancer target

Phase 3 trial confirms Lumakras role in lung cancer

Merck takeover talks with Seagen have hit a hurdle; report

Radiopharma specialist Aktis' first-round financing swells t...

J&J gets first approval for multiple myeloma bispecific Tecv...

NCI sets aside $23m to research telehealth in cancer care

Aligning with national efforts to modernise cancer diagnosti...

How to meet your physicians where they are online

News

Editor's Picks